Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
Medicine Availability
Support

Home > News & Updates > Regulatory Updates > Controlled Substances > Quota Allocation of Drug Substance for Product Development Studies

Quota Allocation of Drug Substance for Product Development Studies

Abdul Qadir Controlled Substances December 22, 2025December 22, 2025

document-4 Download

Share this:

Twitter
Facebook

← 123. Recall Alert (Class-I) – Drug Products (Human) Substandard – Gligit Baltistan.
Training on online module for issuance of CRF-Nothing Due Certificate(NDC) By MIS Division, DRAP (For all pharmaceutical industry) →

Drugs
Medical Devices
Alternative Medicines
Controlled Substances
Licensing and Inspections
Clinical Trials
Pharmacovigilance
Advertisements
General

Quick Navigation

Quick Navigation

Registered Drugs Index
Drug Pricing Index
List of Pharmaceutical Units

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem